Nintendo Shares Jump as Switch 2 Sales Boost Earnings 
Goldman Sachs Sees US Stock Buybacks Outpacing Equity Issuance as AI Funding Rises 
Daimler Truck Q2 Profit Falls 18%, 2026 Outlook Raised 
UOB Q2 Net Profit Rises 10% as Wealth Management Growth Boosts Earnings 
Alphabet Stock Slides as Google AI Pioneer Jeff Dean Exits to Launch Discovery Loop 
Nvidia to Invest Up to $3 Billion in Blackstone-Backed Lancium 
Deutsche Bank Upgrades Persimmon to Buy After Strong First-Half Results 
Berkshire Hathaway Cash Falls as Abel Boosts Stock Buybacks 
SK Hynix, Samsung Lead Asian Chip Stock Selloff After Sandisk, Western Digital Outlook 
SanDisk Q4 Earnings Beat Estimates as Q1 Revenue Outlook Meets Expectations 
AMP Shares Surge 13% After Strong Profit and A$150 Million Buyback 
Western Digital Q4 Earnings Beat Estimates as FY2027 Outlook Tops Expectations 
Apple Tests China’s CXMT Memory Chips for iPhones and MacBooks Amid AI Supply Crunch 
Nvidia Seen Beating Q2 Targets as Vera Rubin Cycle Begins 
Treasury Wine Estates Shares Jump as U.S. Overhaul Lifts FY2026 Outlook 
Cloudflare Stock Jumps 15% as Earnings Beat Estimates, 2026 Outlook Raised 
SoftBank Q1 Profit Beats Forecast as Intel Rally and OpenAI Investments Boost Returns 
NEW YORK, Feb. 22, 2018 -- Guanidinoacetic acid (GAA) or Glycocyamine is the biochemical precursor of creatine, which is phosphorylated. It plays an important role as a high-energy carrier in the muscle. Glycocyamine is actually a metabolite of glycine in which the amino group has been converted into a guanidine. Guanidinoacetic acid can be used to increase muscle strength and to reduce muscle fatigue. And add guanidinoacetic acid into fodder can make lean pig’s body improve significantly. GAA might be considered as an innovative way to improve exercise performance. It has recently been suggested as a possible alternative to creatine to tackle brain creatine levels in experimental medicine. Due to upgraded bioavailability and convenient utilization of the compound, taking GAA orally might be beneficial for AGAT patients. But it has several drawbacks like brain methylation issues, neurotoxicity, and hyperhomocysteinemia.
From studies it has been observed that a combination of betaine and glycocyamine improves the symptoms of patients with chronic illness, including heart disease, without toxicity. Betaine provides methyl group to glycocyamine, via methionine, for the formation of creatine. Because of this, such treatment led to less fatigue, greater strength and endurance, and an improved sense of well-being. It is also useful for the patients with cardiac decompensation (arteriosclerosis or rheumatic disease) and congestive heart failure for improving cardiac function. It is also helpful in gained weight (improved nitrogen balance) and saw lessened symptoms of arthritis and asthma and increased libido. People suffering from hypertension experienced transient reduced blood pressure. It also increase of glucose tolerance in both diabetic and without diabetes subjects.
Free Sample Request: https://www.profsharemarketresearch.com/sample/guanidinoacetic-acid-market-report-sample/
Guanidinoacetic Acid Market: By Product Type
• Feed Grade
• Pharmaceutical Grade
Guanidinoacetic Acid Market: End Users/ Applications
• Fodder
• Medicine
Guanidinoacetic Acid Market: Regional Analysis
1.2.1 North America
• U.S.A
1.2.2 Europe
• Germany
• France
• Italy
• Spain
• UK
• Rest of Europe
1.2.3 Asia Pacific
• China
• Japan
• India
• South Korea
1.2.4 Latin America
• Brazil
1.2.5 Middle East and Africa
Guanidinoacetic Acid Market: Companies Covered
• Evonik (Germany)
• GENDONE (China)
• HebeiDaxiao (China)
• TianchengChempharm (China)
• Lubon Industry (China)
• Hubei Yuanhua (China)
• Jiangsu Yuanyang (China)
• Shijiazhuang Zexing (China)
Buy Reports: https://www.profsharemarketresearch.com/buy/guanidinoacetic-acid-market-report-buy-su/
Contact Us:
Mia Cox,
Email- [email protected]
Tel- 1-877-797-7295
www.profsharemarketresearch.com
